The 32nd annual congress of ECTRIMS began yesterday, September 14th, 2016, in London, England and will run through September 17th. We’re following the best ECTRIMS 2016 coverage and…
Category: MS News
I was thrilled to be able to participate in the National MS Society’s Public Policy Conference (PPC) in March. It is by far my favorite MS advocacy event, and I look forward to it all year. This year we focused on three issues: funding for MS research, the Neurological Diseases Act, and making MS medications more affordable and accessible.
Ten, nine, eight… The end of 2015 means we’re a year closer to finding the answers and a cure for multiple sclerosis. Before we ring in 2016, let’s take a look back at all the progress made and lessons learned this year. Biggest MS Headlines in 2015 There were a lot of attention-grabbing headlines in 2015. Here’s a look […]
Over the past 15 years multiple sclerosis (MS) treatments have come a long way. MS is easier to diagnose now than it was in the past, and we have 12 different disease modifying drugs (DMDs) for people with relapsing-remitting MS. This is a huge step in the right direction, but we still have a long […]
Every year, more than 300 MS activists meet in Washington, DC to discuss important legislation and funding for MS research efforts during the…
Research participants are just as important as the scientists conducting clinical trials. Even if you don’t want to participate in drug trials, there is still a lot you can do to help that puts you at little to no risk.
Two MIT students built a game-changing assistive device for $100 to help a guy with MS and pretty much restored my faith in humanity…
MS HOPE Foundation is proud to have been invited to the Judith Jaffe Multiple Sclerosis Clinical Care & Research Center’s inaugural MS informational event: “Conversations About Multiple Sclerosis.” And you’re invited, too!
We’re thrilled to read that our friend Dr. Timothy Vartanian and his team’s research on a newly discovered potential environmental MS trigger has been published in the PLoS ONE Medical Journal! Check out the press release after the jump!